Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.10% | 125.14 | 0.0% | $2517.24m | |
| BNGO | BioNano Genomics, Inc. | -11.93% | 8.05 | 0.0% | $1626.30m | |
| GILD | Gilead Sciences, Inc. | 1.37% | 67.99 | 1.0% | $696.88m | |
| AMGN | Amgen, Inc. | 1.65% | 252.36 | 1.3% | $574.64m | |
| CRSP | CRISPR Therapeutics AG | -4.30% | 189.77 | 0.6% | $516.52m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.57% | 542.27 | 2.7% | $477.27m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.61% | 157.74 | 2.0% | $471.04m | |
| NVAX | Novavax, Inc. | -2.31% | 125.05 | 92.9% | $463.88m | |
| ILMN | Illumina, Inc. | 3.42% | 403.54 | 3.5% | $395.72m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.04% | 96.76 | 13.8% | $351.95m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.07% | 236.70 | 1.9% | $351.25m | |
| BIIB | Biogen, Inc. | -1.30% | 270.28 | 1.7% | $328.68m | |
| BNTX | BioNTech SE | -1.40% | 103.23 | 0.0% | $308.28m | |
| OCGN | Ocugen, Inc. | -4.70% | 2.23 | 0.0% | $294.71m | |
| PACB | Pacific Biosciences of California, Inc. | -4.02% | 38.59 | 7.4% | $258.16m |
Company Profile
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.